johnsonjohnson
Johnson & Johnson (JNJ.N) announced on Wednesday a significant move towards resolving ongoing litigation over its baby powder and other talc products, with a proposed settlement amounting to $6.475 billion. This substantial figure is aimed at settling tens of thousands of lawsuits alleging that the company’s talc products contain asbestos and could cause ovarian cancer. Johnson & Johnson plans settlement via subsidiaryThe healthcare giant plans to manage this settlement through a third bankruptcy filing of a subsidiary, LTL Management, specifically created to handle J&J’s talc liabilities. Thi...
Invezz
Key Points Johnson & Johnson stock had a strong quarter, and shares are moving higher.The company raised guidance for the year and it may be cautious.The stock confirms support at a long-term uptrend line and is ready to rebound higher.5 stocks we like better than Johnson & JohnsonAfter three years of waiting, Johnson & Johnson (NYSE:JNJ) shares have returned to trend, a monumental event for the market which presents a potential buying opportunity for income investors. Find A Qualified Financial Advisor Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in yo...
ValueWalk
Research has revealed the largest legal settlements in history and how much these enormous payouts would be worth in today’s economy. The Top Ten Largest Lgal SettlementsAmong the settlements was the infamous case that saw Volkswagen exposed for deceiving customers by rigging 11 million vehicles to cheat emissions tests. At the time of settlement, the German car manufacturers were ordered to pay $14.7 billion to settle civil charges, as well as reimbursements to those deceived customers. Since the settlement, inflation has dictated that the value of this payout sits at a hefty $18.6 billion, a...
ValueWalk
According to the article by Reuters, “The labor market has remained tight, with 1.6 job openings for every unemployed person in March, well above the 1.0-1.2 range that is consistent with a jobs market that is not generating too much inflation.” This opens up an opportunity to look closely at sectors that benefit from a strong jobs market. How Does a Strong Jobs Market Help Investors?Increased Consumer SpendingA strong jobs market generally leads to increased employment levels and income growth. When the general population has jobs, more disposable income is available. Consumers tend to spend ...
ValueWalk
What’s New In Activism – ValueAct Takes Stake In SpotifyValueAct Capital Management took a stake in music streaming company Spotify Technology SA (NYSE:SPOT) in a move expected to push for a tightening on spending and overall efficiencies. The new position was disclosed by the hedge fund’s CEO Mason Morfit during a Friday presentation at Columbia University in New York. Q4 2022 hedge fund letters, conferences and more "Spotify's superpower was combining engineering breakthroughs with organizational abilities — it organized creators and copyright owners to build an entirely new economic model t...
ValueWalk
The institutions are buying Johnson & Johnson and Abbot Laboratories.The two are Dividend Kings with the power to continue raising their dividends for years.One is ready to rebound, the other to continue leading the broad market higher.If you are looking for a healthy dividend in the healthcare sector, look no further than Abbott Laboratories (NYSE:ABT). These companies are among the highest-quality Dividend Kings not just in their industry; they both have the power to continue raising their dividends long into the future. Add in fact the institutions are buying them and there is an opportunit...
ValueWalk
Johnson & Johnson Moves Up On Mixed ResultsJohnson & Johnson (NYSE:JNJ) is, if nothing else, a workhorse among stocks and one any investor could own. The company’s business is more than entrenched, it often trades at a discount to the S&P 500, it delivers steady consistent growth, and it pays a nice dividend. That’s why we’re not surprised to see it moving higher after what can only be called a mixed report. The takeaway from the report, however, is the core business, business ex-COVID, is just as healthy as it ever was. What this means for investors is steady if slow growth, a healthy balance...
ValueWalk
Q1 2022 hedge fund letters, conferences and more Johnson & Johnson Raises DividendsI just read that Johnson & Johnson (JNJ) has hiked dividends by 6.60% to $1.13/share. This marked the 60th consecutive annual dividend increase for this dividend king. There are only 38 companies in the US which have managed to increase dividends annually for at least 50 years in a row. Over the past decade, Johnson & Johnson has managed to grow dividends at an annualized rate of 6.40%/year. When reviewing press releases that discuss dividend increases, I always find it helpful to see the tone from top managemen...
ValueWalk
Following is the unofficial transcript of a CNBC interview with Johnson & Johnson (NYSE:JNJ) CEO Joaquin Duato and CNBC’s Senior Health & Science Reporter Meg Tirrell live during CNBC’s “Healthy Returns Summit: Reality, Recovery and Opportunity” today, Wednesday, March 30. CNBC’s Interview With Johnson & Johnson CEO Joaquin Duato____ MEG TIRRELL: I want to bring in now our first guest Joaquin Duato, the CEO of Johnson & Johnson. J&J of course was instrumental in the vaccine race for COVID-19. We’re going to talk about that but Joaquin first I just want to welcome you. You know first time we’ve...
ValueWalk
Following are excerpts from the unofficial transcript of a CNBC interview with National Institute of Allergy and Infectious Diseases Director & White House Chief Medical Advisor Dr. Anthony Fauci, on “Squawk Box” (M-F, 6AM-9AM ET) today, Friday, December 17th. Following are links to video on CNBC.com: Q3 2021 hedge fund letters, conferences and more Dr. Anthony Fauci: If Covid Counts Keep Increasing, We 'May Need To Be More Restrictive'Dr. Anthony Fauci Weighs In On Holiday Gatherings, Travel Amid OmicronFauci On RecommendationsThe recommendations are what we have always said. We got to get th...
ValueWalk
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら